Experimental models of portal hypertension;Modeles experimentaux d'hypertension portale

Gastroenterologie Clinique et Biologique

Volumn 24, Issue 10, 2000, Pages 896-901

  Oberti, Frédéric ^a   Vuillemin, Eric ^a   Fort, Joël ^a   CalèS, Paul ^a  

^a ANGERS UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BILIARY CIRRHOSIS; EXPERIMENTAL MODEL; HEMODYNAMICS; HISTOPATHOLOGY; PORTAL HYPERTENSION; PORTOSYSTEMIC ANASTOMOSIS; REVIEW; ANIMAL; DISEASE MODEL; LIGATION; LIVER CIRRHOSIS; PATHOLOGY; PATHOPHYSIOLOGY; PORTAL VEIN;

ANIMALS; DISEASE MODELS, ANIMAL; HEMODYNAMIC PROCESSES; HYPERTENSION, PORTAL; LIGATION; LIVER CIRRHOSIS; PORTAL VEIN;

EID: 0034296943     PISSN: 03998320     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (59)

1. Animal models of portal hypertension
2. Experimental models of hepatic fibrosis: A review
3. Carbon tetrachloride cirrhosis in relation to liver regeneration
4. Carbon tetrachloride hepatotoxicity: An example of lethal cleavage
5. 4 an adequate model of human cirrhosis ?
6. Synergism between ethanol and carbon tetrachloride in the generation of liver fibrosis
7. Acetone potentiation of chronic liver injury induced by repetitive administration of carbon tetrachloride
8. Modeles experimentaux de l'hypertension portale
9. High yield micronodular cirrhosis in the rat
10. Thioacetamide- and carbon tetrachloride-induced liver cirrhosis
11. The role of capillarization in hepatic failure: Studies in carbon tetrachloride-induced cirrhosis
12. Inhibition of nitric oxide production increases dimethylnitrosamine-induced liver injury in rats
13. A dimethylnitrosamine-induced model of cirrhosis and portal hypertension in the rat
14. The role of pericentral fibrosis in experimental portal hypertension in rats
15. Dimethylnitrosamine-induced cirrhosis: Evidence for an immunological mechanism
16. Metabolic and hemodynamic responses of bivascularly perfused rat liver to nerve stimulation, noradrenaline, acetylcholine and glucagon in thioacetamide-induced micronodular cirrhosis
17. Hemodynamic characterization in experimental liver cirrhosis induced by thioacetamide administration
18. Thioacetamide-induced cirrhosis-like liver lesions in rats: Usefulness and reliability of this animal model
19. Ligation of the common bile duct
20. Elevated serum aminoterminal procollagen type-III-peptide parallels collagen accumulation in rats with secondary biliary fibrosis
21. Non suppurative cholangitis is induced in neonatally thymectomized mice: A possible animal model for primary biliary cirrhosis
22. Prolonged bile duct obstruction: A new experimental model for cirrhosis in the rat
23. Potential role of bile duct collaterals in the recovery of the biliary obstruction: Experimental study in rats using microcholangiography, histology, serology and magnetic resonance imaging
24. Alpha-interferon prevents liver collagen deposition and damage induced by prolonged bile duct obstruction in the rat
25. Origin, pattern, and mechanism of bile duct proliferation following biliary obstruction in the rat
26. Biliary retention in a chronic choledoco-venous fistula in the rat: Induction of portal hypertension but not of biliary cirrhosis
27. Structure-function relationship in secondary biliary cirrhosis in the rat: Stereologic and hemodynamic characterization of a model
28. Experimental biliary fibrosis correlates with increase numbers of fat-storing and kupffer cells, and portal endotoxemia
29. Reversibility of secondary biliary fibrosis by biliodigestive anastomosis in the rat
30. Hepatic stellate cells (Ito cells) but not collagen IV may partly be responsible for lower portal pressure after reversing secondary biliary cirrhosis in the rat
31. Portal hypertension in the rat
32. Prehepatic portal hypertension in the rat
33. Model for the study of portal-systemic collateral vascular resistance in the conscious rat
34. Intrahepatic portal occlusion by microspheres: A new model of portal hypertension in the rat
35. Effects of dietary polyinsatured fat on ethanol-induced ito cell activation
36. Correlation of intrahepatic pressure with collagen in the Disse space and hepatomegaly in humans and in the rat
37. Phosphatidyl choline protects against fibrosis and cirrhosis in the baboon
38. Hepatic fibrosis after long-term administration of ethanol and moderate vitamin A supplementation in the rat
39. The integrated value of serum procollagen III peptide over time predicts hepatic hydroxyproline content and stainable collagen in a model of dietary cirrhosis in the rat
40. Polyenylphosphatidylcholine attenuates non-alcoholic hepatic fibrosis and accelerates its regression
41. Propranolol ameliorates the development of portal-systemic shunting in a chronic murine schistosomiasis model of portal hypertension
42. The effect of alcohol-induced hepatomegaly on portal hypertension in cirrhotic rats
43. Evolution of portal hypertension and mechanisms involved in its maintenance in a rat model
44. Hemodynamic studies in long- and short-term portal hypertensive rats: The relation to systemic glucagon levels
45. Hyporeactivity of mesenteric resistance arteries in portal hypertensive rats
46. Mesenteric vasodilator responses in cirrhotic rats: A role for nitric oxyde
47. Increased endothelial nitric oxyde activity in the hyperemic vessels of portal hypertensive rats
48. Prevention of portal hypertension and porto-systemic shunts by early chronic administration of clonidine in conscious portal vein-stenosed rats
49. Administration of N-nitro-L-arginine ameliorates portal-systemic shunting in portalhypertensive rats
50. Divergent circulatory effect of betaxolol in conscious and anesthetized normal and portal hypertensive rats
51. Hemodynamic characterization of chronic bile duct-ligated rats: Effect of pentobarbital sodium
52. Cardiovascular hyporesponsiveness to norepinephrine, propranolol and nitroglycerin in portal-hypertensive and aged rats
53. Effect of development on the functionnal and histological changes induced by bile-duct ligation in the rat
54. Comparison of the circulation between fed and fasted normal and portal hypertensive rats
55. Early chronic administration of propranolol reduces the severity of portal hypertension and portal-systemic shunts in conscious portal vein stenosed rats
56. Propranolol ameliorates the development of portal-systemic shunting in a chronic murine shistosomiasis model of portal hypertension
57. Prevention of portal hypertension by propranolol and spironolactone in rats with bile duct ligation
58. Effects of long term administration of octreotide in portal vein stenosed rats
59. Antifibrotic and hemodynamic effects of the early and chronic administration of octreotide in two models of liver fibrosis in rats